Johnson & Johnson Coronavirus Vaccine Enters Late-Stage Trial Testing
Johnson & Johnson Coronavirus Vaccine Enters Late-Stage Trial Testing

Johnson & Johnson's Covid-19 vaccine candidate begins Phase 3 trials.

Veuer’s Maria Mercedes Galuppo has the story.